We came across a bullish thesis on AstraZeneca PLC on Disruptive analytics’s Substack by Magnus Ofstad. In this article, we will summarize the bulls’ thesis on AZN. AstraZeneca PLC's share was trading at $85.31 as of October 3rd. AZN’s trailing and forward P/E were 31.51 and 16.31 respectively according to Yahoo Finance.
[caption id="attachment_519743" align="aligncenter" width="750"]AstraZeneca is a leading player in antibody-drug conjugates (ADCs) and targeted cancer therapies, with a strong portfolio spanning both...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.